Inhibition of in vitro Ebola infection by anti-parasitic quinoline derivatives

There continues to be no approved drugs for the treatment of Ebola virus disease (EVD). Despite a number of candidate drugs showing limited efficacy in vitro and/or in non-human primate studies, EVD continues to plaque certain areas of Africa without any efficacious treatments yet available. Recentl...

Descripción completa

Detalles Bibliográficos
Autores principales: Goyal, Shawn, Binnington, Beth, McCarthy, Stephen D.S., Desmaële, Didier, Férrié, Laurent, Figadère, Bruno, Loiseau, Philippe M., Branch, Donald R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268155/
https://www.ncbi.nlm.nih.gov/pubmed/32528661
http://dx.doi.org/10.12688/f1000research.22352.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268155/
https://www.ncbi.nlm.nih.gov/pubmed/32528661
http://dx.doi.org/10.12688/f1000research.22352.1

Ejemplares similares